Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three licensed areas to inject Wegovy are the abdomen, the front of the thigh, and the outer upper arm. Each site works well, but rotating between them each week keeps the tissue healthy and helps absorption stay consistent. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before any treatment begins. This page covers every site in practical detail so you go into your first injection with confidence.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy's licensed injection sites are the stomach area (abdomen), the front of the thigh, and the outer upper arm. All three deliver the medicine into subcutaneous fat, the soft layer just beneath the skin. That route is important: going too shallow (into the skin itself) stings and reduces absorption; going too deep (into muscle) is uncomfortable and also changes how the medicine is taken up.
On the abdomen, aim for the area at least two inches away from the navel, working around the full circumference rather than always injecting at the same clock position. The thigh site is the front or outer surface, roughly the middle third of the upper leg, avoiding the inner thigh and the knee. For the upper arm, use the fleshy outer part, about halfway between the shoulder and elbow — this is easiest with a helper or if you can steady the arm against a surface, though the Wegovy pen's design makes solo arm injections manageable. You can read more about the arm site specifically on our guide to Wegovy arm injections.
The NHS semaglutide guidance confirms these three sites and describes the subcutaneous technique; always keep your Patient Information Leaflet to hand for the illustrated step-by-step that came in the box.
Consistency of technique matters more than which specific area you pick. That said, rotating systematically does matter. Injecting into the same small patch week after week creates a build-up of fibrous tissue called lipohypertrophy: a hard, lumpy area that looks and feels different and, crucially, slows absorption in ways that can make your dose less predictable.
A practical system many people use is to divide the abdomen into quadrants and work around them, or to alternate abdomen one week, thigh the next. What you want to avoid is a favourite spot that always gets the pen. A question our prescribers hear most weeks is whether the abdomen is the best area to inject Wegovy, and the honest answer is that it is the easiest site for most people to inject solo, but absorption across all three licensed areas is clinically equivalent when technique is right. You can find a more detailed comparison in our guide to the best area for Wegovy injection if you want to think through the options before your first pen arrives.
One practical detail: if you are also using another injectable medicine at the same site (insulin, for example), pick a different area for that injection on the same day. You do not need to change which region you use for Wegovy, just avoid the exact same patch of skin.
Certain spots are off-limits regardless of which body area you are using. Skip any skin that is red, bruised, tender, infected or hardened from previous injections. On the abdomen, stay at least five centimetres from the navel; on the thigh, avoid the inner surface and the area close to the knee. For a thorough look at technique, our Wegovy injection guide walks through preparing the pen, confirming the injection has delivered, and what to do with the used pen afterwards, including safe disposal via a sharps container.
Skin preparation also counts. Cleaning the chosen spot with an alcohol swab and letting it dry fully before injecting reduces the risk of irritation. If you want step-by-step guidance covering everything from attaching the needle cap to disposing of the used device, our page on Wegovy injections walks through each stage in plain language. A small red dot or mild itching immediately afterwards is common and usually settles within an hour or two. Persistent pain, swelling or signs of infection at the site are worth reporting to your prescriber or GP.
If you are travelling and want guidance on keeping the pen at the right temperature away from home, our page on packing Wegovy for travel covers storage windows and what to do if the cold chain is interrupted.
Comfort is personal. The abdomen tends to be the least sensitive for most people because there is usually more subcutaneous fat and fewer nerve endings near the surface compared with the thigh. The thigh can feel sharper, particularly on leaner legs where the fatty layer is thinner. The arm is often rated somewhere in between.
There is no clinical evidence that one of the three licensed areas produces faster or greater weight loss than another; the deciding factor is consistent weekly use with proper rotation. NHS England's guidance on weight-management injections reinforces that technique and ongoing clinical oversight together determine how well treatment goes. Semaglutide (the active ingredient in Wegovy) is a once-weekly subcutaneous injection, and the pen is designed so that a spring-loaded mechanism does the hard part: you press, hold, and it delivers.
If you are weighing up Wegovy against other options, our weight-loss treatments overview sets out what is currently licensed in the UK. And if you have questions that are not covered here, our FAQs are worth a look before you get in touch.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.